Labs / CDMO: development & manufacturing
Crossbow
Cambridge, MA, United States · crossbowtx.com
On your own
Free. Their own form.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Crossbow Therapeutics develops antibody-based cancer immunotherapies, including TCR-mimetic antibodies and T-cell engagers. It focuses on identifying and validating cancer antigens and advancing programs for cancers and other serious diseases.
They take quote requests by email.
What they offer
TCR-mimetic antibody discovery
Develops highly potent and highly accurate antibodies that target tumor-specific peptides presented by MHC and mimic T-cell receptors.
T-Bolt™ molecule development
Incorporates TCRm antibodies into T-cell engagers and other immunotherapies to optimize manufacturability and potency while minimizing tumor resistance.
What they work on
- Modalities
- Antibody, Bispecific, Peptide, Cell therapy
- Therapeutic areas
- cancer, AML, MDS, CML, HR-MDS, CMML, sqNSCLC, HNSCC, ovarian cancer, esophageal cancer, autoimmune disorders
- Address
- 1030 Massachusetts Ave. Suite 210 Cambridge, MA 02138
Public records
- Ownership
- Crossbow B.V. · CW GLEIF
Similar labs. Sparx BIO, Alphalyse, Asimov, Aurigene Pharmaceutical Services
Found in a contract services directory. Listing built from crossbowtx.com. Work here? Claim this listing.